Cargando…
Advances in treatment and prevention of hepatitis B
Chronic hepatitis B (CHB) continues to contribute to worldwide morbidity and mortality significantly. Scientists, clinicians, pharmaceutical companies, and health organizations have dedicated substantial Intellectual and monetary resources to finding a cure, increasing immunization rates, and reduci...
Autores principales: | Shah, Niraj James, Aloysius, Mark M, Sharma, Neil Rohit, Pallav, Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290928/ https://www.ncbi.nlm.nih.gov/pubmed/34316384 http://dx.doi.org/10.4292/wjgpt.v12.i4.56 |
Ejemplares similares
-
Impact of Race and Socioeconomics Disparities on Survival in Young-Onset Colorectal Adenocarcinoma—A SEER Registry Analysis
por: Aloysius, Mark M., et al.
Publicado: (2021) -
Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?
por: Shah, Niraj James, et al.
Publicado: (2017) -
Recent Advances in Hepatitis B Treatment
por: Prifti, Georgia-Myrto, et al.
Publicado: (2021) -
Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016) -
Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
por: Kim, Soo Ryang, et al.
Publicado: (2023)